Ning Xu

1PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 31, 2022
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma.

Ning Xu, Erin Yu, Nicole Ng

Pageof 1

Frequent Collaborators

1 joint publications

James R Berenson